Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Trenbolone Enanthate Industry to hit 91.5 million dollars by 2031: Coherent Market Insights

      This image opens in the lightbox

      News provided by

      Coherent Market Insights

      19 Jun, 2024, 15:25 GMT

      Share this article

      Share this article


      BURLINGAME, Calif., June 19, 2024 /PRNewswire/ --The global trenbolone enanthate market is expected to increase from USD 75.6 million in 2024 to USD 91.5 million by 2031, registering a CAGR of 2.8% between 2024 and 2031, as per a recent report by Coherent Market Insights. The growing popularity of the sport means there is ever increasing demand for supplements and steroids that can help build muscle quickly. Trenbolone Enanthate remains one of the most sought after steroids due to its reputation as a very potent mass builder. As bodybuilding gains more mainstream recognition and followership, the market for Trenbolone Enanthate and related products will continue expanding rapidly.

      Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/6886

      Market Dynamics:

      The global Trenbolone Enanthate market is primarily driven by rising demand for anabolic steroids from bodybuilders and athletes across the globe. Trenbolone enanthate is one of the most commonly used anabolic steroids for bulking and cutting cycles due to its high anabolic and low androgenic properties. It promotes significant gains in muscle mass and strength within short span without much emphasis on water retention. Additionally, increasing awareness about benefits of trenbolone enanthate such as fat loss, vascularity, and muscle hardness is further propelling the market growth.

      Trenbolone Enanthate Market Report Coverage

      Report Coverage

      Details

      Market Revenue in 2024

      $75.6 million

      Estimated Value by 2031

      $91.5 million

      Growth Rate

      Poised to grow at a CAGR of 2.8%

      Historical Data

      2019–2023

      Forecast Period

      2024–2031

      Forecast Units

      Value (USD Million/Billion)

      Report Coverage

      Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

      Segments Covered

      By Type, By Application, By Distribution Channel

      Geographies Covered

      North America, Europe, Asia Pacific, and Rest of World

      Growth Drivers

      • Growing Awareness of The Benefits of Greater Muscle

      • Increasing Demand for Enanthate

      Restraints & Challenges

      • Regulatory Restrictions and Legal Issues

      • Side Effects Associated with The Use of Trenbolone Enanthate

      Market Trends:

      Injectable route has been the most popular and prevalent form of trenbolone enanthate administration. Ease of dosage and regular monitoring of its impact has driven higher preference of injections over other forms such as oral pills.

      Availability of trenbolone enanthate and other steroids through online pharmacies and underground labs has been a significant trend. Consumers find it convenient to order these products privately without visiting medical stores or gyms. This has significantly influenced the sales through e-commerce channels.

      Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/6886

      The trenbolone enanthate powder segment accounts for the major share in the trenbolone enanthate market. Trenbolone enanthate powder is preferred due to its easy availability, stability during storage and transportation, and cost-effectiveness. It is widely used in the manufacture of trenbolone enanthate injections as well as for research purposes. The stability and ease of handling of trenbolone enanthate powder makes it the dominant form in the market.

      The pharmaceutical applications segment holds the largest share in the trenbolone enanthate market. Trenbolone enanthate finds wide usage in various pharmaceutical preparations due to its anabolic and androgenic properties. It is commonly used in hormone replacement therapies, treatment of wasting disorders, and dietary supplements. The increasing cases of muscle wasting conditions and hormonal imbalances are driving the demand for trenbolone enanthate from pharmaceutical manufacturers.

      Key Market Takeaways:

      The global trenbolone enanthate market is anticipated to witness a CAGR of 2.8% during the forecast period 2024-2031, owing to rising awareness about fitness and bodybuilding.

      On the basis of type, trenbolone enanthate powder segment is expected to hold a dominant position, accounting for over 60% of the market share due to its stability and cost-effectiveness.

      On the basis of application, pharmaceuticals segment will dominate the market due to wide usage of trenbolone enanthate in hormone therapies and muscle building formulations. By distribution channel, hospital pharmacies are expected to be the largest segment owing to the availability of prescribed medications.

      On the basis of region, North America is expected to hold a dominant position over the forecast period, due to well-developed healthcare infrastructure and growing medical expenditures in the region.

      Key players operating in the trenbolone enanthate market include Kosher Pharmaceuticals, LEXICARE PHARMA PVT. LTD., Niva Lifecare, Dragon Pharma, Mulan Pharma Pvt., Ltd., Cooper Pharma, Alpha-Pharma Healthcare, Genesis Global Pharma, Meditech Pharmaceutical. These players are focusing on new product launches and expansion strategies to gain a competitive edge in the market.

      Customize this study as per your requirement: https://www.coherentmarketinsights.com/insight/request-customization/6886

      Detailed Segmentation-

      By Type:

        • Trenbolone Enanthate Powder
        • Trenbolone Enanthate Injection

      By Application:

        • Pharmaceuticals
        • Veterinary Medicine

      By Distribution Channel:

        • Hospital Pharmacies
        • Retail Pharmacies
        • Others

      By Region:

      North America:

        • U.S.
        • Canada

      Latin America:

        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America

      Europe:

        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe

      Asia Pacific:

        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific

      Middle East:

        • GCC Countries
        • Israel
        • Rest of Middle East

      Africa:

        • South Africa
        • North Africa
        • Central Africa

      Browse More Insights:

      Testosterone Replacement Therapy Market, by Route of Administration (Injectables, Parenteral), by Active Ingredient Type (Testosterone, Methyl Testosterone, Testosterone Undecanoate, Testosterone Enanthate, and Testosterone Cypionate) and by Geography

      Androgen Replacement Therapy Market: The Global androgen replacement therapy market is estimated to be valued at US$ 2,276.6 Mn in 2023 and is expected to exhibit a CAGR of 7.8% during the forecast period (2023-2030).

      About Us:

      Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

      Contact Us:
      Mr. Shah
      Senior Client Partner – Business Development
      Coherent Market Insights
      Phone:
      US: +1-206-701-6702
      UK: +44-020-8133-4027
      Japan: +81-050-5539-1737
      India: +91-848-285-0837
      Email: sales@coherentmarketinsights.com
      Website: https://www.coherentmarketinsights.com
      Follow Us: LinkedIn | Twitter

      Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.